Philadelphia, PA, October 27, 2016 – Anexinet Corporation, a digital, analytics, and hybrid IT solution company, announced today that they received the “Innovator of the Year” from the Smart CEO-Marcum Innovator of the Year Program, which honors Greater Philadelphia’s most innovative companies.
Recognized for the innovated Unstructured Data Analytics with its ListenLogic Insights Platform, Anexinet created a powerful new approach, which enterprises can use to gain market and operational intelligence derived from all forms of unstructured data.
ListenLogic Insights Platform delivers insight for a variety of descriptive and predictive analytical problems such as improving customer attrition, increasing revenue and sensing reputation risk. The platform performs data ingestion, cleansing and categorization of unstructured data using voice, text analytics and machine learning to “structure” unstructured data. Delivered as an end-to-end managed service, the platform is operated by Anexinet analysts leveraging deep vertical expertise to model and synthesize results.
“The market for unstructured and structured data analysis is exploding and Anexinet is at the forefront of solution providers that address this market need,” said Joseph Lanzisera, CEO. “Anexinet can blend the structured data with unstructured data from call centers, social media, email, and chatbots to collect new insights, predict outcomes and mitigate risk.”
Unstructured data analytics gives Anexinet a key advantage when working with clients in that we can analyze all external or internal datasets and make sense of it individually or integrate it with other data.
Anexinet’s ListenLogic platform provides enterprises with comprehensive views into their customers supporting multiple use cases including:
|
|
|
|
|
|
|
|
|
|
|
|
- Customer Attrition Analysis
|
|
Over a span of three years, Anexinet’s Unstructured Data Analytics solution, powered by ListenLogic Insights Platform, has been adopted at over 25 Fortune 500 organizations and nearly half of the Top 20 Life Science companies.
